TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1
Article (February 2024)
The most recent citing publications are shown below. View all 58 publications that cite this research output on Dimensions.
Article (February 2024)
Article in European Journal of Pharmacology (October 2023)
Article in Vacunas (English Edition) (October 2023)